How Would You Treat These Patients?
A Live Virtual Clinic in PAH
October 21, 2020 | 4:45 PM - 5:45 PM CDT

    Presented through a collaboration between Medscape and Albert Einstein College of Medicine-Montefiore Medical Center.

    LIVE Virtual Symposium

    Participants can access this live virtual event on OCTOBER 21, 2020 from 4:45 PM - 5:45 PM CDT.

    Activity Overview

    This engaging live symposium led by experts in the field of pulmonary arterial hypertension (PAH) will take learners through interactive case-based discussions designed to improve clinicians' ability to effectively diagnose and treat PAH in clinical practice.

    • Vallerie McLaughlin, MD
      Professor of Cardiovascular Medicine
      Director, Pulmonary Hypertension Program
      University of Michigan
      Ann Arbor, Michigan
    • Murali Chakinala, MD
      Professor of Medicine
      Director, Washington University and Barnes-Jewish Hospital Pulmonary Hypertension Care Center
      Washington University
      St Louis, Missouri
    Program Wednesday, October 21, 2020
    • 4:45 PM
    • Welcome and Introduction
      Vallerie McLaughlin, MD
      • Current State of PAH
    • Case 1 Presentation: Newly Diagnosed Patient
      Murali Chakinala, MD
    • Panel Discussion
    • Case 2 Presentation: Patient Who Has Been Treated but Not Meeting Goal
      Vallerie McLaughlin, MD
    • Panel Discussion
    • Summary
    • 5:45 PM
    • Live Q&A

    Enhance your experience with MedChallenge! This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

    Win a donation to the charity of your choice! Be the top MedChallenge player at the end of the event to win a $100 donation to a charity of your choosing.

    Click here and play NOW!

    Learning Objectives
    • Have greater competence related to
      • Patient assessment to determine risk status for patients with PAH
      • Selection of therapy in PAH to achieve low-risk status
      • The use of effective strategies to address adherence and tolerance in patients with PAH
    Target Audience
    Goal Statement
    Credits Available
    • 1.0
    • For Physicians
    Accreditation Statement
    Your home!
    Supported by an independent educational grant from
    Actelion: A Janssen Pharmaceuticals Company of
    Johnson and Johnson and United Therapeutics Corporation.